TLR4 plays a crucial role in MSC-induced inhibition of NK cell function

Biochemical and Biophysical Research Communications

Volumn 464, Issue 2, 2015, Pages 541-547

  Lu, Ying ^a   Liu, Jin ^b   Liu, Yang ^b   Qin, Yaru ^b   Luo, Qun ^a   Wang, Quanli ^a   Duan, Haifeng ^b  

^a Beijing 307 Hospital   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Anti tumor immunity; MSC; NK cells; TLR4

Indexed keywords

5' NUCLEOTIDASE; ENDOGLIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2D; THY 1 ANTIGEN; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; K562 CELL LINE; MESENCHYMAL STROMA CELL; MOUSE; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; FEMALE; HELA CELLS; HUMANS; IMMUNOPHENOTYPING; K562 CELLS; KILLER CELLS, NATURAL; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; TOLL-LIKE RECEPTOR 4; TUMOR MICROENVIRONMENT;

EID: 84938289385     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.07.002     Document Type: Article

References (35)

1. M. Allinen, R. Beroukhim, L. Cai, C. Brennan, J. Lahti-Domenici, H. Huang, D. Porter, M. Hu, L. Chin, A. Richardson, S. Schnitt, W.R. Sellers, and K. Polyak Molecular characterization of the tumor microenvironment in breast cancer Cancer Cell 6 2004 17 32
2. K. Pietras, J. Pahler, G. Bergers, and D. Hanahan Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting PLoS Med. 5 2008 e19
3. L.E. Littlepage, M. Egeblad, and Z. Werb Coevolution of cancer and stromal cellular responses Cancer Cell 7 2005 499 500
4. X. Su, J. Ye, E.C. Hsueh, Y. Zhang, D.F. Hoft, and G. Peng Tumor microenvironments direct the recruitment and expansion of human Th17 cells J. Immunol. 184 2010 1630 1641
5. J.L. Barnas, M.R. Simpson-Abelson, S.P. Brooks, R.J. Kelleher Jr. , and R.B. Bankert Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors J. Immunol. 185 2010 2681 2692
6. A. Cerwenka, and L.L. Lanier Natural killer cells, viruses and cancer Nat. Rev. Immunol. 1 2001 41 49
7. T. Li, Y. Yang, X. Hua, G. Wang, W. Liu, C. Jia, Y. Tai, Q. Zhang, and G. Chen Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO Cancer Lett. 318 2012 154 161
8. T. Li, S. Yi, W. Liu, C. Jia, G. Wang, X. Hua, Y. Tai, Q. Zhang, and G. Chen Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity Med. Oncol. 30 2013 663
9. K. Bieback, S. Kern, A. Kocaomer, K. Ferlik, and P. Bugert Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood Biomed. Mater. Eng. 18 2008 S71 S76
10. C.M. Digirolamo, D. Stokes, D. Colter, D.G. Phinney, R. Class, and D.J. Prockop Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate Br. J. Haematol. 107 1999 275 281
11. N.Z. Kuhn, and R.S. Tuan Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis J. Cell. Physiol. 222 2010 268 277
12. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 2007 557 563
13. R.H. Goldstein, M.R. Reagan, K. Anderson, D.L. Kaplan, and M. Rosenblatt Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis Cancer Res. 70 2010 10044 10050
14. A.P. Molloy, F.T. Martin, R.M. Dwyer, T.P. Griffin, M. Murphy, F.P. Barry, T. O'Brien, and M.J. Kerin Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells Int. J. Cancer 124 2009 326 332
15. C. Zhang, W. Zhai, Y. Xie, Q. Chen, W. Zhu, and X. Sun Mesenchymal stem cells derived from breast cancer tissue promote the proliferation and migration of the MCF-7 cell line Oncol. Lett. 6 2013 1577 1582
16. G.M. Spaggiari, A. Capobianco, S. Becchetti, M.C. Mingari, and L. Moretta Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation Blood 107 2006 1484 1490
17. A. Pradier, J. Passweg, J. Villard, and V. Kindler Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity Cell. Transplant. 20 2011 681 691
18. G.M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M.C. Mingari, and L. Moretta Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 Blood 111 2008 1327 1333
19. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
20. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
21. S.E. Haynesworth, M.A. Baber, and A.I. Caplan Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies Bone 13 1992 69 80
22. A.M. Mackay, S.C. Beck, J.M. Murphy, F.P. Barry, C.O. Chichester, and M.F. Pittenger Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow Tissue Eng. 4 1998 415 428
23. B. Zavan, C. Giorgi, G.P. Bagnara, V. Vindigni, G. Abatangelo, and R. Cortivo Osteogenic and chondrogenic differentiation: comparison of human and rat bone marrow mesenchymal stem cells cultured into polymeric scaffolds Eur. J. Histochem. 51 Suppl. 1 2007 1 8
24. C. Kuperwasser, T. Chavarria, M. Wu, G. Magrane, J.W. Gray, L. Carey, A. Richardson, and R.A. Weinberg Reconstruction of functionally normal and malignant human breast tissues in mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 4966 4971
25. C. Berking, R. Takemoto, H. Schaider, L. Showe, K. Satyamoorthy, P. Robbins, and M. Herlyn Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling Cancer Res. 61 2001 8306 8316
26. T.V. Byzova, C.K. Goldman, N. Pampori, K.A. Thomas, A. Bett, S.J. Shattil, and E.F. Plow A mechanism for modulation of cellular responses to VEGF: activation of the integrins Mol. Cell. 6 2000 851 860
27. P.P. Goh, D.M. Sze, and B.D. Roufogalis Molecular and cellular regulators of cancer angiogenesis Curr. Cancer Drug Targets 7 2007 743 758
28. C. Servais, and N. Erez From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation J. Pathol. 229 2013 198 207
29. C. Gaggioli, S. Hooper, C. Hidalgo-Carcedo, R. Grosse, J.F. Marshall, K. Harrington, and E. Sahai Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells Nat. Cell. Biol. 9 2007 1392 1400
30. N.C. Direkze, and M.R. Alison Bone marrow and tumour stroma: an intimate relationship Hematol. Oncol. 24 2006 189 195
31. P.J. Mishra, R. Humeniuk, D.J. Medina, G. Alexe, J.P. Mesirov, S. Ganesan, J.W. Glod, and D. Banerjee Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells Cancer Res. 68 2008 4331 4339
32. J. Harper, and R.C. Sainson Regulation of the anti-tumour immune response by cancer-associated fibroblasts Semin. Cancer Biol. 25 2014 69 77
33. S.A. Patel, J.R. Meyer, S.J. Greco, K.E. Corcoran, M. Bryan, and P. Rameshwar Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta J. Immunol. 184 2010 5885 5894
34. S.D. Kundu, C. Lee, B.K. Billips, G.M. Habermacher, Q. Zhang, V. Liu, L.Y. Wong, D.J. Klumpp, and P. Thumbikat The Toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells Prostate 68 2008 223 229
35. M. Fukata, A. Chen, A.S. Vamadevan, J. Cohen, K. Breglio, S. Krishnareddy, D. Hsu, R. Xu, N. Harpaz, A.J. Dannenberg, K. Subbaramaiah, H.S. Cooper, S.H. Itzkowitz, and M.T. Abreu Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors Gastroenterology 133 2007 1869 1881